Tracking Innovation with Thermo Fisher Scientific: CPHI Americas Track Sponsor interview

As we gear up for CPHI Americas from May 20-22, 2025 at the Philadelphia Convention Center, we sat down with Track Sponsor Thermo Fisher Scientific to discuss the future of bioproduction in pharma. 

What do you hope to highlight with the Bio-innovation Track? 

We aim to showcase the value of outsourcing buffer and process liquid manufacturing, emphasizing the flexibility and scalability available through the right partner. While outsourcing may initially seem like a significant shift, collaborating with a partner that offers customized, scalable solutions can make the transition seamless and highly beneficial to long-term growth.  

What are some key and emerging trends within the R&D space for pharma? 

Key emerging trends in pharmaceutical R&D include the development of more targeted and advanced antibody modalities, such as bispecific antibodies and antibody-drug conjugates. Additionally, the continued expansion in the scope and therapeutic potential of cell therapy is driving innovation across the field.  

How important will bioproduction and bio-manufacturing be for the future of pharma? 

Bioproduction is fundamental to the future of the pharmaceutical industry. The number of biologics under review by the FDA and global regulatory agencies has steadily increased. Coupled with the rapid growth of cell and gene therapy markets, a robust bioproduction infrastructure is essential for supporting innovation and meeting future therapeutic demands. 

What does it mean for Thermo Fisher Scientific to be sponsoring this year’s CPHI Americas Bio-innovation track? 

It’s an honor to sponsor this year’s R&D and Bio-Manufacturing Track. At Thermo Fisher Scientific, we are committed to advancing scientific discovery through collaboration. Events like CPHI foster critical partnerships that continue to shape the future of biomanufacturing and drive progress across the industry. 

What are you most looking forward to this year at CPHI Americas? 

We are excited to reconnect with existing collaborators and partners, and equally enthusiastic about building new relationships within the CPHI community. These interactions are vital to fostering innovation and advancing shared goals across the pharmaceutical ecosystem. 

Discover the full CPHI Americas agenda here and plan your trip today!